0.00 Vol 0 
The Bermuda Stock Exchange is now a MIAXTM Company
Horizon Pharma Investment Limited a company registered in Bermuda under registration number EC50064 and is a wholly-owned subsidiary of Horizon Pharma plc (“the Parent”).
The Issuer’s Parent, Horizon Pharma, is a specialty biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring or in-licensing and commercializing differentiated products that address unmet medical needs. Horizon Pharma markets a portfolio of products in arthritis, inflammation and orphan diseases.
The proceeds of the 2.50% senior notes due 15 March 2022 are intended for general corporate purposes.
| Title | Description | Date Posted |
|---|---|---|
 2019 Financials |
2019 Financials | 2020/07/14 |
| 2018 Financials |
2018 Financials | 2019/09/06 |
| 2017 Financials |
2017 Financials | 2018/08/13 |
| 2016 Financials |
2016 Financials | 2018/08/13 |
| 2015 Financials |
2015 Financials | 2016/09/13 |
| TRADING HOURS | LOCATION |
|---|---|
| 08:30-09:00 Price Discovery | Exchange House |
| 09:00-16:30 Continuous Trading | 110 Pitts Bay Road |
| Pembroke, Bermuda | |
| CONTACT DETAILS | MAILING ADDRESS |
| TEL: +1 (441) 292 7212 | P.O. Box HM 1369 |
| FAX: +1 (441) 292 7619 | Hamilton HMFX |
| Contact Us (info@bsx.com) |
| DISCLAIMER |
|---|
| The information contained in these pages has been obtained from sources which The Bermuda Stock Exchange believes are reliable. However, the accuracy of the information cannot and is not guaranteed and The Bermuda Stock Exchange makes no representation as to its accuracy or completeness. Neither this Web site, nor any information contained herein, constitutes advice or a solicitation to subscribe, purchase or sell any securities. The Bermuda Stock Exchange expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon any part of the contents of this site or any external sites referenced from this website. |